BioAtla Return on Equity (ROE) Growth & History (BCAB)

BioAtla's return on equity was −164.30% for fiscal 2024.

View full BioAtla company overview

BioAtla annual return on equity history

BioAtla annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20242024-12-31−164.30%−65.93 pp
20232023-12-31−98.37%−43.93 pp
20222022-12-31−54.44%−9.10 pp
20212021-12-31−45.34%+1.23 pp
20202020-12-31−46.57%

BioAtla return on equity trends

Between the periods ended 2020-12-31 and 2024-12-31, BioAtla's return on equity decreased from −46.57% to −164.30%, a change of −117.73 percentage points. The latest reported quarter, Q1 2025, shows −207.05%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BioAtla source filings ↗

Community posts

It’s quiet here.

No posts about BCAB yet. Start the conversation.

Write the first post